JenaValve Technology Inc

IRVINE, CA · Founded 2006 · Medtech · Private

Transcatheter aortic valve replacement (TAVR) device with commissural locator technology for aortic regurgitation

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · jenavalve.com

Sector
Medtech
Headquarters
IRVINE, CA
Founded
2006
Latest Form D
$8M, Jan 2022
Total capital
$185M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$185M
9 Form D · last Jan 2022
58 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
31
9 pending · first 2020
Rank in peer group#44 of 1112

Capital timeline

2010201220142016201820202022FEDERAL ↑EQUITY ↓Cumulative $185M2nd Form D$62.5M
2010201420182022FEDERAL ↑EQUITY ↓Cumulative $185M

Latest events

  • Private capital raisedForm D · SEC · 9th filing$8M
  • Private capital raisedForm D · SEC · 8th filing$35.5M
  • Private capital raisedForm D · SEC · 7th filing$14.5M
  • Private capital raisedForm D · SEC · 6th filing$4.9M
  • Private capital raisedForm D · SEC · 5th filing$9.4M
  • Private capital raisedForm D · SEC · 4th filing$10M
  • Private capital raisedForm D · SEC · 3rd filing$26.5M
  • Private capital raisedForm D · SEC · 2nd filing$62.5M
  • Private capital raisedForm D · SEC · 1st filing$13.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#44 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Helmut StraubingerResearcherExecutive Officer, DirectorLinked by 3 patents
  • Andrew HackDirectorNamed in SEC Form D filings
  • Arnd KaltofenDirectorNamed in SEC Form D filings
  • Carl Christian Gilhuus-MoeDirectorNamed in SEC Form D filings
  • Daniel DearenDirectorNamed in SEC Form D filings
  • David DrachmanExecutive Officer, DirectorNamed in SEC Form D filings
Show all 31 people
  • Erik AmbleDirectorNamed in SEC Form D filings
  • Hans-Reiner FigullaDirectorNamed in SEC Form D filings
  • Jan KeltjensDirectorNamed in SEC Form D filings
  • Jan PensaertDirectorNamed in SEC Form D filings
  • John KilcoyneExecutive Officer, DirectorNamed in SEC Form D filings
  • Jose Calle GordoDirectorNamed in SEC Form D filings
  • Jose (Pepe) Calle GordoDirectorNamed in SEC Form D filings
  • Kari MooreExecutive OfficerNamed in SEC Form D filings
  • Keith DawkinsDirectorNamed in SEC Form D filings
  • Kenneth MacLeodDirectorNamed in SEC Form D filings
  • Markus FerrariDirectorNamed in SEC Form D filings
  • Michael DormerDirectorNamed in SEC Form D filings
  • Olivier LitzkaDirectorNamed in SEC Form D filings
  • Ouyang XiangyuDirectorNamed in SEC Form D filings
  • Patrick van BenedenDirectorNamed in SEC Form D filings
  • Peter BarrettDirectorNamed in SEC Form D filings
  • Peter WulffExecutive OfficerNamed in SEC Form D filings
  • Quan ZhouDirectorNamed in SEC Form D filings
  • Raymond CohenDirectorNamed in SEC Form D filings
  • Regina HoditsDirectorNamed in SEC Form D filings
  • Robert MitchellDirectorNamed in SEC Form D filings
  • Rudi MarienDirectorNamed in SEC Form D filings
  • Stephan WehselauExecutive OfficerNamed in SEC Form D filings
  • van Beneden PatrickDirectorNamed in SEC Form D filings
  • Victoria Carr-BrendelExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 31 granted of 40
Show all 40 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .